BIOMOLECULE - BINDERS

A Biomolecule Binder is a specif designed protein that binds to other proteins or biomolecules in an organism producing an intended effect, such as a biomedicine or a reagent for In-Vitro diagnosis.

CRAID Methodology has the unique technology capable of designing De-Novo BINDERs in days instead of years, that can be used as reagents for In-Vitro diagnosis or as biomedicines.

The following BINDERs are been provided by Ixilka Biotech filiated CORPs for investors and colaborators, as well as for clinical trials and pharmaceutical industry.

     Ask COPILOT ... Why to join a CORP?      Why to invest?
CoV2r11x CoVID Hypercytokinemia Antigen Receptor with fluorescence
Professional Use Research Use and In-House In-Vitro Diagnosis for Long-Covid or COVID Hypercytokinemia
Validated Licensing for In-House development at POC and Health Institutions
Offer the service      CTO/Industry     
B-EYE1 Crystallin β b2 CRYBB2 Binder for ionic bond reconstitution
Research Research Use Only
Modelling Scientific base modelling and CORP promoting
Join CORP      CTO/Industry     
B-AxD2 GFAP-Z110 anticatalytic biomolecule binder as potential biomedicine for Alexander disease and IVD reagent
Research In-Silico human interactome assay trial and protocol definition for In-Vitro validation
Validating In-Vitro Ex-Vivo promoting study of the hypothesis and functional validation
Join CORP      Patients     
B-NAHS Antigen blocking of zoonotic H5N1 variants
Potential veterinary nutritional complement for blocking zoonotic variants
Starting Defining resources and scope
Join CORP     
N-BORR Neutralizing Borrelia decoy antigens
Potential biomedicine for Lyme disease
Modelling Scientific base modelling and CORP promoting
Join CORP      Patients     
B-CTHx Bind-Blocker of prostate tumor promoters
Potential biomedicine for prostate cancer
Modelling Scientific base modelling and CORP promoting
Join CORP      Patients     
N-FAPx Neutralizing-Binder of FAP mutant proteases
Potential biomedicine for Hepatocellular Carcinoma and Cholangiocarcinoma
Modelling Scientific base modeling and CORP promoting
Join CORP      Patients     

These biomolecules are studied as potential biomedicines and/or biomarkers in each respective project. None are sold as medicines or medical devices for patients; they are intended solely for investors and pharmaceutical development.
Further information is provided below:

Business Model      General Terms      Contact us